Elisa
Garbayo Atienza
Profesional Investigadora
Instituto de Investigación Sanitaria de Navarra
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Navarra (30)
2024
-
Navigating the landscape of RNA delivery systems in cardiovascular disease therapeutics
Advanced Drug Delivery Reviews, Vol. 208
-
Rna-loaded nanoparticles for the treatment of hematological cancers
Advanced Drug Delivery Reviews, Vol. 214
2023
-
Cardiac tissue engineering for myocardial infarction treatment
European Journal of Pharmaceutical Sciences, Vol. 185
-
Lipid nanoparticles for siRNA delivery in cancer treatment
Journal of Controlled Release, Vol. 361, pp. 130-146
2022
-
Development of an injectable alginate-collagen hydrogel for cardiac delivery of extracellular vesicles
International Journal of Pharmaceutics, Vol. 629
-
Encapsulation of MSCs and GDNF in an Injectable Nanoreinforced Supramolecular Hydrogel for Brain Tissue Engineering
Biomacromolecules, Vol. 23, Núm. 11, pp. 4629-4644
-
Hydrogels for brain repair: application to Parkinson’s disease
Expert Opinion on Drug Delivery, Vol. 19, Núm. 11, pp. 1521-1537
-
Isolation methods of large and small extracellular vesicles derived from cardiovascular progenitors: A comparative study
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 170, pp. 187-196
-
Nanomedicines and cell-based therapies for embryonal tumors of the nervous system
Journal of Controlled Release, Vol. 348, pp. 553-571
-
Special issue on the latest advances in regenerative medicine and cancer using drug delivery systems
European Journal of Pharmaceutics and Biopharmaceutics
2021
-
Delivery of cardiovascular progenitors with biomimetic microcarriers reduces adverse ventricular remodeling in a rat model of chronic myocardial infarction
Acta Biomaterialia, Vol. 126, pp. 394-407
-
Extracellular vesicle-based therapeutics for heart repair
Nanomaterials, Vol. 11, Núm. 3, pp. 1-30
-
Optimization of a GDNF production method based on Semliki Forest virus vector
European Journal of Pharmaceutical Sciences, Vol. 159
2020
-
Nanomedicine and drug delivery systems in cancer and regenerative medicine
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, Vol. 12, Núm. 5
2019
-
Long-term engraftment of human cardiomyocytes combined with biodegradable microparticles induces heart repair
Journal of Pharmacology and Experimental Therapeutics, Vol. 370, Núm. 3, pp. 761-771
-
Micro- and nanotechnology approaches to improve Parkinson's disease therapy
Journal of Controlled Release, Vol. 295, pp. 201-213
-
NRG1 PLGA MP locally induce macrophage polarisation toward a regenerative phenotype in the heart after acute myocardial infarction
Journal of Drug Targeting, Vol. 27, Núm. 5-6, pp. 573-581
-
Nanobiotechnology in parkinson’s disease
Nanobiotechnology in Neurodegenerative Diseases (Springer International Publishing), pp. 177-208
2018
-
Advances in parkinson’s disease: 200 years later
Frontiers in Neuroanatomy, Vol. 12
-
Heart tissue repair and cardioprotection using drug delivery systems
Maturitas, Vol. 110, pp. 1-9